Werbung
Werbung

XTNT

XTNT logo

Xtant Medical Holdings, Inc.

0.69
USD
Gesponsert
-0.01
-1.97%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

0.71

+0.02
+3.21%

XTNT Ergebnisberichte

Positives Überraschungsverhältnis

XTNT übertreffen die 13 der letzten 28Schätzungen.

46%

Nächster Bericht

Datum des nächsten Berichts
04. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$31.36M
/
$0.00
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-5.68%
/
-100.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-0.47%
/
-100.00%

Xtant Medical Holdings, Inc. earnings per share and revenue

On 10. Nov. 2025, XTNT reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of 0.00 USD, resulting in a 296.08% surprise. Revenue reached 33.26 million, compared to an expected 33.35 million, with a -0.30% difference. The market reacted with a -0.62% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 31.36 million USD, implying an decrease of -100.00% EPS, and decrease of -5.68% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, Xtant Medical Holdings, Inc. reported EPS of $0.01, beating estimates by 296.08%, and revenue of $33.26M, -0.3% below expectations.
The stock price moved down -0.62%, changed from $0.76 before the earnings release to $0.76 the day after.
The next earning report is scheduled for 04. März 2026.
Based on 4 analysts, Xtant Medical Holdings, Inc. is expected to report EPS of -- and revenue of $31.36M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung